Concurrent losses of skeletal muscle mass, adipose tissue and bone mineral density during bevacizumab / cytotoxic chemotherapy treatment for metastatic colorectal cancer
Adeline Dolly, Thierry Lecomte, Olivier Bouché, Christophe Borg, Éric Terrebonne, Jean‐Yves Douillard, Romain Chautard, William Raoul, David Ternant, Julie Léger, A. Bleuzen, Jean‐François Dumas, Stéphane Servais, Vickie E. Baracos
Topics & Concepts
MedicineBevacizumabAdipose tissueColorectal cancerOncologyBone mineralChemotherapyInternal medicineCancerCytotoxic T cellCancer researchOsteoporosisBiochemistryIn vitroChemistryNutrition and Health in AgingBone health and treatmentsCancer Risks and Factors